Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 1/20 | 0.46 |
| ▸ | MME | P08473 | 3/20 | 0.45 |
| ▸ | ENPEP | Q07075 | 11/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1235820 | 0.91 | MME (0.51) | ACEMMEENPEP | |
| SCHEMBL2061990 | 0.91 | MME (0.51) | ACEMMEENPEP | |
| SCHEMBL29615164 | 0.90 | ECE1 (0.51) | ACE | |
| SCHEMBL29606984 | 0.89 | BACE1 (0.43) | MMEENPEP | |
| SCHEMBL30011166 | 0.89 | ACE (0.59) | ACEMME | |
| SCHEMBL30313441 | 0.89 | BACE1 (0.43) | MMEENPEP | |
| SCHEMBL30011175 | 0.89 | ACE (0.59) | ACEMME | |
| SCHEMBL19934813 | 0.89 | ACE (0.59) | ACEMME | |
| SCHEMBL30010893 | 0.89 | ACE (0.59) | ACEMME | |
| SCHEMBL30186400 | 0.88 | ACE (0.54) | ACEMMEENPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4707386-A1 | ARTIFICIAL VIRUS CAPSID | AGC INC. (JP) | 2026-03-11 | — | — | EP | disclosed |
| US-20260049107-A1 | ARTIFICIAL VIRAL CAPSID | AGC Inc. (JP) | 2026-02-19 | — | — | US | disclosed |
| WO-2024228371-A1 | ARTIFICIAL VIRUS CAPSID | ＡＧＣ株式会社 | 2024-11-07 | — | — | WO | disclosed |
| US-20240287131-A1 | PEPTIDE | AGC Inc. (JP) | 2024-08-29 | — | — | US | disclosed |
| CN-117999272-A | Peptides | ＡＧＣ株式会社 | 2024-05-07 | — | — | CN | disclosed |
| WO-2023048236-A1 | PEPTIDE | ＡＧＣ株式会社 | 2023-03-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240287131-A1 | PEPTIDE | SSTR5, SSTR4, NGLY1 | ACE 1989/4885MME 997/4885ENPEP 325/4885 |
| US-20260049107-A1 | ARTIFICIAL VIRAL CAPSID | ZC3HAV1L, ZFR, SLC39A11 | ACE 2671/4885MME 976/4885ENPEP 1679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.